...
首页> 外文期刊>Journal of Surgical Oncology >Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma.
【24h】

Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma.

机译:封装是大肝细胞癌预后较好的重要预后因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The aim of this study was to determine the effect of tumor encapsulation of hepatocellular carcinoma (HCC) on long-term survival. METHODS: A retrospective review of 1,240 patients who underwent hepatectomy from January 1993 to June 2005 was conducted. There were 891 patients with tumor encapsulation (EC type) and 349 patients without tumor encapsulation (NC type). Clinicopathological factors, surgical outcome, and long-term survival were analyzed. RESULTS: Disease-free survival (DFS) was affected by surgical margin involvement, the presence of surgical complications, vascular invasion, liver cirrhosis, tumor encapsulation, tumor size >5 cm, tumor rupture, and the presence of satellite lesions (all, P < 0.05). Overall survival (OS) was also affected by the same parameters, except for satellite lesions. When the patients were grouped by tumor size >5 or 5 cm [odds ratio (OR) for DFS = 0.75, P = 0.02; OR for OS = 0.68, P < 0.01]. CONCLUSIONS: Tumor encapsulation is a significant prognostic factor for HCC >5 cm.
机译:背景:这项研究的目的是确定肝细胞癌(HCC)的肿瘤封装对长期生存的影响。方法:回顾性分析1993年1月至2005年6月接受肝切除术的1,240例患者。有891例有肿瘤包膜的患者(EC型)和349例没有肿瘤包膜的患者(NC型)。临床病理因素,手术结果和长期生存进行了分析。结果:无病生存期(DFS)受手术切缘累及,手术并发症,血管侵犯,肝硬化,肿瘤包膜,肿瘤大小> 5 cm,肿瘤破裂和附属病变的影响。 <0.05)。除卫星病变外,总生存期(OS)也受相同参数的影响。当患者按肿瘤大小> 5或≤5cm分组时,只有在肿瘤大小> 5 cm时才观察到包封的保护作用[DFS = 0.75,P = 0.02的比值比(OR);对于OS = 0.68,或P <0.01]。结论:肿瘤包封是HCC> 5 cm的重要预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号